# Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

> **NCT00864110** · PHASE1 · COMPLETED · sponsor: **Cell>Point LLC** · enrollment: 4 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **RADIATION:** Radiolabeled (99Tc) EC-DG (ethylenedicysteine-deoxyglucose)
- **RADIATION:** Technetium 99m ethylenedicysteine-deoxyglucose
- **RADIATION:** 18 F fluorodeoxyglucose

## Key facts

- **NCT ID:** NCT00864110
- **Lead sponsor:** Cell>Point LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2013-03-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864110, "Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00864110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*